<?xml version='1.0' encoding='utf-8'?>
<document id="15205386"><sentence text="An evaluation of the in vitro metabolism data for predicting the clearance and drug-drug interaction potential of CYP2C9 substrates." /><sentence text="In the early drug discovery process, metabolic stability and cytochrome P450 inhibition are often used as an early selection tool to identify useful compounds for further development" /><sentence text=" The reliability of the data in this process is therefore crucial" /><sentence text=" In the present study, in vitro enzyme kinetic data were used to predict the in vivo clearance and drug-drug interaction potential of four well known CYP2C9 substrates (tolbutamide, fluvastatin, ibuprofen and diclofenac) that are frequently used as benchmark substances in screening programs"><entity charOffset="169-180" id="DDI-PubMed.15205386.s4.e0" text="tolbutamide" /><entity charOffset="182-193" id="DDI-PubMed.15205386.s4.e1" text="fluvastatin" /><entity charOffset="195-204" id="DDI-PubMed.15205386.s4.e2" text="ibuprofen" /><entity charOffset="209-219" id="DDI-PubMed.15205386.s4.e3" text="diclofenac" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e0" e2="DDI-PubMed.15205386.s4.e0" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e0" e2="DDI-PubMed.15205386.s4.e1" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e0" e2="DDI-PubMed.15205386.s4.e2" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e0" e2="DDI-PubMed.15205386.s4.e3" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e1" e2="DDI-PubMed.15205386.s4.e1" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e1" e2="DDI-PubMed.15205386.s4.e2" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e1" e2="DDI-PubMed.15205386.s4.e3" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e2" e2="DDI-PubMed.15205386.s4.e2" /><pair ddi="false" e1="DDI-PubMed.15205386.s4.e2" e2="DDI-PubMed.15205386.s4.e3" /></sentence><sentence text=" Quantitative predictions of hepatic clearance using the well stirred prediction model and CL(int) calculated from enzyme kinetic measurements were not useful" /><sentence text=" Including and excluding protein binding resulted in under- and overestimation, respectively, of in vivo clearance" /><sentence text=" The only predicted in vivo clearance that fell into the range of reported measured values was for fluvastatin when protein binding was not included"><entity charOffset="99-110" id="DDI-PubMed.15205386.s7.e0" text="fluvastatin" /></sentence><sentence text=" In an open, randomized, seven-armed, crossover study in healthy volunteers, tolbutamide, ibuprofen, and fluvastatin were investigated as inhibitors of the metabolism of diclofenac, and vice versa"><entity charOffset="77-88" id="DDI-PubMed.15205386.s8.e0" text="tolbutamide" /><entity charOffset="90-99" id="DDI-PubMed.15205386.s8.e1" text="ibuprofen" /><entity charOffset="105-116" id="DDI-PubMed.15205386.s8.e2" text="fluvastatin" /><entity charOffset="170-180" id="DDI-PubMed.15205386.s8.e3" text="diclofenac" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e0" e2="DDI-PubMed.15205386.s8.e0" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e0" e2="DDI-PubMed.15205386.s8.e1" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e0" e2="DDI-PubMed.15205386.s8.e2" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e0" e2="DDI-PubMed.15205386.s8.e3" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e1" e2="DDI-PubMed.15205386.s8.e1" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e1" e2="DDI-PubMed.15205386.s8.e2" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e1" e2="DDI-PubMed.15205386.s8.e3" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e2" e2="DDI-PubMed.15205386.s8.e2" /><pair ddi="false" e1="DDI-PubMed.15205386.s8.e2" e2="DDI-PubMed.15205386.s8.e3" /></sentence><sentence text=" None of the combinations was found to interact with each other in vivo" /><sentence text=" The in vitro drug-drug interaction potential was investigated by K(i) determinations of the same combinations" /><sentence text=" In contrast to clearance predictions, the interaction potential in vivo was best predicted when plasma protein binding was included in the various models used" /><sentence text=" This study points to the uncertainty in calculating in vivo kinetics from in vitro enzyme kinetic data" /><sentence text=" The in vitro metabolic screening can thus be questioned as a compound selection tool without a proven in vitro-in vivo correlation" /><sentence text="" /></document>